Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis C
SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.
HCP Live Staff
Advertisement
Articles by HCP Live Staff
Advertisement
Latest Updated Articles
Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis CPublished: October 15th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Less Common Pneumococcal Serotypes Cause More Severe Community-Acquired Pneumonia
3
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
4
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
5
